International Journal of Infection

Published by: Kowsar

High Prevalence of HTLV-1 Infection Among Hemodialysis Patients in Neyshabur, Northeast of Iran

Mohammad Reza Hedayati-Moghaddam 1 , * , Farhad Fathimoghadam 1 , Leyla Soghandi 2 and Ahmad Darrudi 3
Authors Information
1 Blood Borne Infections Research Center, Academic Center for Education, Culture and Research, Khorasan Razavi Branch, Mashhad, Iran
2 Hakim Hospital, Neyshabur University of Medical Sciences, Neyshabur, Iran
3 22-Bahman Hospital, Neyshabur University of Medical Sciences, Neyshabur, Iran
Article information
  • International Journal of Infection: 6 (1); e85164
  • Published Online: January 22, 2019
  • Article Type: Research Article
  • Received: October 9, 2018
  • Revised: November 22, 2018
  • Accepted: December 11, 2018
  • DOI: 10.5812/iji.85164

To Cite: Hedayati-Moghaddam M R , Fathimoghadam F , Soghandi L , Darrudi A . High Prevalence of HTLV-1 Infection Among Hemodialysis Patients in Neyshabur, Northeast of Iran, Int J Infect. Online ahead of Print ; 6(1):e85164. doi: 10.5812/iji.85164.

Abstract
Copyright © 2019, International Journal of Infection. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Johnson JM, Harrod R, Franchini G. Molecular biology and pathogenesis of the human T-cell leukaemia/lymphotropic virus Type-1 (HTLV-1). Int J Exp Pathol. 2001;82(3):135-47. doi: 10.1046/j.1365-2613.2001.00191.x. [PubMed: 11488989]. [PubMed Central: PMC2517711].
  • 2. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-I infection and associated diseases. Oncogene. 2005;24(39):6058-68. doi: 10.1038/sj.onc.1208968. [PubMed: 16155612].
  • 3. Gallo RC. The discovery of the first human retrovirus: HTLV-1 and HTLV-2. Retrovirology. 2005;2:17. doi: 10.1186/1742-4690-2-17. [PubMed: 15743526]. [PubMed Central: PMC555587].
  • 4. Gessain A, Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol. 2012;3:388. doi: 10.3389/fmicb.2012.00388. [PubMed: 23162541]. [PubMed Central: PMC3498738].
  • 5. Rostamzadeh Khameneh Z, Baradaran M, Sepehrvand N. Survey of the seroprovalence of HTLV I/II in hemodialysis patients and blood donors in Urmia. Saudi J Kidney Dis Transpl. 2008;19(5):838-41. [PubMed: 18711311].
  • 6. Rafatpanah H, Hedayati-Moghaddam MR, Fathimoghadam F, Bidkhori HR, Shamsian SK, Ahmadi S, et al. High prevalence of HTLV-I infection in Mashhad, Northeast Iran: A population-based seroepidemiology survey. J Clin Virol. 2011;52(3):172-6. doi: 10.1016/j.jcv.2011.07.004. [PubMed: 21840754].
  • 7. Hedayati-Moghaddam MR, Fathimoghadam F, Eftekharzadeh Mashhadi I, Soghandi L, Bidkhori HR. Epidemiology of HTLV-1 in Neyshabour, northeast of Iran. Iran Red Crescent Med J. 2011;13(6):424-7. [PubMed: 22737506]. [PubMed Central: PMC3371930].
  • 8. Salehi M, Shokouhi Mostafavi SK, Ghasemian A, Gholami M, Kazemi-Vardanjani A, Rahimi MK. Seroepidemiology of HTLV-1 and HTLV-2 infection in Neyshabur city, North-Eastern Iran, during 2010-2014. Iran Biomed J. 2017;21(1):57-60. doi: 10.18869/acadpub.ibj.21.1.57. [PubMed: 26899860]. [PubMed Central: PMC5141255].
  • 9. Azarpazhooh MR, Hasanpour K, Ghanbari M, Rezaee SA, Mashkani B, Hedayati-Moghaddam MR, et al. Human T-lymphotropic virus type 1 prevalence in northeastern Iran, Sabzevar: An epidemiologic-based study and phylogenetic analysis. AIDS Res Hum Retroviruses. 2012;28(9):1095-101. doi: 10.1089/AID.2011.0248. [PubMed: 22229796].
  • 10. Mobini M, Salehi M. Prevalence of human T-cell leukemia virus antibodies among young females attending a large medical diagnostic laboratory in Neyshabour, Northeast of Iran, during 2011 to 2015. Arch Clin Infect Dis. 2018;13(3). e62305. doi: 10.5812/archcid.62305.
  • 11. Yazdani R, Dadmanesh M, Ghorban K. First report of the prevalence of human T-lymphotropic virus type 1 (HTLV-1) for hemodialysis patients in Tehran. Arch Clin Infect Dis. 2018;13(4). e65512. doi: 10.5812/archcid.65512.
  • 12. Ghaffari J, Naghshvar F, Nazari Z, Farid R, Torabizadeh J, Madani F. Seroprevalence of human T-cell lymphotropic virus type 1 infection (HTLV1) in different patients in the north of Iran. Afr J Biotechnol. 2011;10(52):10752-5. doi: 10.5897/ajb11.177.
  • 13. Ghaffari J, Ebrahimi M, Makhlough A, Mohammadjafari H, Nazari Z. Seroepidemiology of human T-cell lymphotropic virus 1 infection in hemodialysis patients: Should we be concerned about it? Iran J Kidney Dis. 2013;7(3):187-90. [PubMed: 23689148].
  • 14. Pourkarim MR, Hajiani GR, Khamisipour GR, Ardeshirdavani N, Tahmasebi R. [Seroepidemiological investigation of HTLV I, II infection among Busherian multi-transfused patients in 2003]. Sci J Iran Blood Transfus Organ. 2005;2(4):99-104. Persian.
  • 15. Pourkarim MR, Khamisipour GR, Zandi K, Roustaei MH. [Prevalence of anti–HTLV-I & anti–HTLV–II antibodies in blood donors in Bushehr province]. Iran South Med J. 2004;6(2):161-4. Persian.
  • 16. Morikawa K, Kuroda M, Tofuku Y, Uehara H, Akizawa T, Kitaoka T, et al. Prevalence of HTLV-1 antibodies in hemodialysis patients in Japan. Am J Kidney Dis. 1988;12(3):185-93. doi: 10.1016/S0272-6386(88)80120-3. [PubMed: 2901222].
  • 17. Eleftheriadis T, Liakopoulos V, Leivaditis K, Antoniadi G, Stefanidis I. Infections in hemodialysis: A concise review. Part II: blood transmitted viral infections. Hippokratia. 2011;15(2):120-6. [PubMed: 22110292]. [PubMed Central: PMC3209673].
  • 18. Ghafouri M, Ameli MR. [Comparing prevalence of transfusion transmitted viral infections in various population groups of South Khorasan]. Sci J Iran Blood Transfus Organ. 2011;7(4):242-8. Persian.
  • 19. Karimi A, Nafici M, Imani R. Comparison of human T-cell leukemia virus type-1 (HTLV-1) seroprevalence in high risk patients (thalassemia and hemodialysis) and healthy individuals from Charmahal-Bakhtiari province, Iran. Kuwait Med J. 2007;39(3):259-61.
  • 20. Abedi F, Yavarian M, Shakibzadeh A, Khalvati B, Asadi AH. [A pilot Seroepidemiologic study of HTLV in thalassemia, hemophilia, and hemodialysed patients in Hormozgan]. Bimon J Hormozgan Univ Med Sci. 2009;13(2):75-80. Persian.
  • 21. Ahmadi Ghezeldasht S, Hassannia T, Rafatpanah H, Hekmat R, Valizadeh N, Ghayour Mobarhan M, et al. Oncogenic virus infections in the general population and end-stage renal disease patients with special emphasis on Kaposi's Sarcoma Associated Herpes Virus (KSHV) in northeast of Iran. Jundishapur J Microbiol. 2015;8(3). e14920. doi: 10.5812/jjm.14920. [PubMed: 25834713]. [PubMed Central: PMC4377171].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments